THE WIRE
What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Key
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.
- TNYATenaya Therapeutics, IncThe Chief Executive Officer sold $1K of stock.$1K−6.6%Form 4 ↗
- TNYATenaya Therapeutics, IncThe Chief Medical Officer sold $1K of stock.$1K−6.6%Form 4 ↗
- RMIXSuncrete, IncA director bought $12K of stock.$12K−22.3%Form 4 ↗
- RMIXSuncrete, IncA director bought $731K of stock.$731K−22.3%Form 4 ↗
- RMIXSuncrete, IncA director bought $55K of stock.$55K−22.3%Form 4 ↗
- RMIXSuncrete, IncThe Chief Operating Officer bought $50K of stock.$50K−22.3%Form 4 ↗
- DUOLDuolingo, IncThe Chief Business Officer sold $208K of stock.$208K−9.5%Form 4 ↗
- DUOLDuolingo, IncThe Chief Engineering Officer sold $785K of stock under a 10b5-1 plan.$785K−9.5%Form 4 ↗
- DUOLDuolingo, IncThe General Counsel sold $515K of stock under a 10b5-1 plan.$515K−9.5%Form 4 ↗
- EXFYExpensify, IncSF Roofdeck GP, a 10% owner, sold $777K of stock.$777K−9.9%Form 4 ↗
- CDNACareDx, IncA director sold $395K of stock under a 10b5-1 plan.$395K−6.0%Form 4 ↗
- EQPTEquipmentShare.com IncThe Founder & President bought $145K of stock.$145K−9.5%Form 4 ↗
- EQPTEquipmentShare.com IncThe Founder & CEO bought $250K of stock.$250K−9.5%Form 4 ↗
- GRABGrab Holdings LtdThe Chief Financial Officer sold $161K of stock under a 10b5-1 plan.$161K−12.4%Form 4 ↗
- KTOSKratos Defense & Security Solutions, IncThe President, STC Division sold $209K of stock under a 10b5-1 plan.$209K−11.1%Form 4 ↗
- OPTUOptimum Communications, IncMilfam Gp, a 10% owner, bought $135K of stock.$135K−13.3%Form 4 ↗
- OIGOrion180 Insurance Group IncA director bought $106K of stock.$106K−4.2%Form 4 ↗
- ARANTERO RESOURCES CorpAn officer sold $1.1M of stock.$1.1M−2.6%Form 4 ↗
- AMAntero Midstream CorpA director sold $1.0M of stock.$1.0M−2.7%Form 4 ↗
- STZConstellation Brands, IncRRA&Z Holdings, a 10% owner, sold $65.2M of stock.$65.3M−1.2%Form 4 ↗
- STZConstellation Brands, IncZMSS Business Management sold $10.9M of stock.$10.9M−1.2%Form 4 ↗
- STZConstellation Brands, IncSSR Business Management sold $21.8M of stock.$21.8M−1.2%Form 4 ↗
- STZConstellation Brands, IncA director sold $21.8M of stock.$21.8M−1.2%Form 4 ↗
- STZConstellation Brands, IncAJB Business Holdings sold $10.9M of stock.$10.9M−1.2%Form 4 ↗
- STZConstellation Brands, IncZachary M Stern sold $10.9M of stock.$10.9M−1.2%Form 4 ↗
- STZConstellation Brands, IncAbigail J Bennett sold $10.9M of stock.$10.9M−1.2%Form 4 ↗
- STZConstellation Brands, IncWSP Holdings Trust, a 10% owner, sold $65.2M of stock.$65.3M−1.2%Form 4 ↗
- STZConstellation Brands, IncRES Business Holdings sold $21.8M of stock.$21.8M−1.2%Form 4 ↗
- STZConstellation Brands, IncA director sold $21.8M of stock.$21.8M−1.2%Form 4 ↗
- ANROAlto Neuroscience, IncThe Chief Operating Officer sold $2.1M of stock.$2.1M−2.1%Form 4 ↗
- REPLReplimune Group, IncThe Chief Medical Officer sold $350K of stock.$350K−3.7%Form 4 ↗
- REPLReplimune Group, IncThe Chief Accounting Officer sold $46K of stock.$46K−3.7%Form 4 ↗
- REPLReplimune Group, IncThe Chief Executive Officer sold $1.1M of stock.$1.1M−3.7%Form 4 ↗
- REPLReplimune Group, IncThe Chief Financial Officer sold $318K of stock.$318K−3.7%Form 4 ↗
- GRDNGuardian Pharmacy Services, IncAn officer sold $251K of stock.$251K−3.9%Form 4 ↗
- GKOSGLAUKOS CorpThe President & COO sold $215K of stock under a 10b5-1 plan.$215K+1.8%Form 4 ↗
- CYTKCytokinetics Inc3 officers sold $1.4M of stock, $583K of it under plans set in advance.$1.4M−1.1%
- CYTKCytokinetics IncThe President & CEO sold $401K of stock under a 10b5-1 plan.$401K−1.1%Form 4 ↗
- CYTKCytokinetics IncThe EVP Research & Development sold $181K of stock under a 10b5-1 plan.$181K−1.1%Form 4 ↗
- CYTKCytokinetics IncThe Chief Legal & Admin Officer sold $795K of stock.$795K−1.1%Form 4 ↗
- FIGFigma, IncA director sold $395K of stock under a 10b5-1 plan.$395K−9.0%Form 4 ↗
- SNAPSnap IncThe Chief Commercial Officer sold $1.3M of stock under a 10b5-1 plan.$1.3M−16.4%Form 4 ↗
- SNAPSnap IncThe Chief Accounting Officer sold $184K of stock under a 10b5-1 plan.$184K−16.4%Form 4 ↗
- SNAPSnap IncThe Chief Financial Officer sold $658K of stock under a 10b5-1 plan.$658K−16.4%Form 4 ↗
- SNAPSnap IncThe General Counsel sold $1.1M of stock under a 10b5-1 plan.$1.1M−16.4%Form 4 ↗
- SEPNSepterna, IncThe Chief Financial Officer sold $832K of stock under a 10b5-1 plan.$832K−2.1%Form 4 ↗
- BIVIBiovie IncThe President & CEO bought $2K of stock.$2K−15.1%Form 4 ↗
- BPREBluerock Private Real Estate FundA director bought $3.2M of stock.$3.2M−4.7%Form 4 ↗
- ANABAnaptysbio, IncA director bought $17.2M of stock.$17.2M−0.9%Form 4 ↗
- BANFBancfirst CorpThe Senior Vice President sold $594K of stock.$594K+0.3%Form 4 ↗
- FTKFlotek Industries IncA director sold $845K of stock.$845K−14.1%Form 4 ↗